semaglutide aka 🎉Exciting news that is now FDA approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% SEMAGLUTIDE – Research Peptide |

It is currently in Phase 3 clinical trials under Eli Lilly's TRIUMPH program

And the way we take it, well this is how you start taking it

Probing binding requirements of NAD kinase with modified substrate (NAD) analogues [PMID: 17258457] Laboratory literature summary: Probing binding requirements of NAD kinase with modified substrate (NAD) analogues

By Week 2 at the same dose, your body is not just experiencing that weeks injection it is experiencing that dose on top of what is already there

In the Teichman trial, the compound's estimated half-life was 5.8-8.1 days, but mean plasma GH rose 2- to 10-fold for six days or more and mean IGF-1 rose 1.5- to 3-fold for 9-11 days after a single injection